MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 7.94% | -12.11% | -4.77% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 50.75% | 53.44% | 22.04% | ||
| Operating Income | -50.75% | -53.44% | -22.04% | ||
| Income Before Tax | -54.70% | -62.21% | -17.98% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -54.70% | -62.21% | -17.98% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -54.70% | -62.21% | -17.98% | ||
| EBIT | -50.75% | -53.44% | -22.04% | ||
| EBITDA | -51.46% | -54.09% | -22.11% | ||
| EPS Basic | -48.26% | -60.91% | -3.71% | ||
| Normalized Basic EPS | -48.26% | -58.36% | -3.71% | ||
| EPS Diluted | -48.26% | -60.91% | -3.71% | ||
| Normalized Diluted EPS | -48.26% | -58.36% | -3.71% | ||
| Average Basic Shares Outstanding | 4.34% | 0.81% | 13.76% | ||
| Average Diluted Shares Outstanding | 4.34% | 0.81% | 13.76% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||